A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

Overview of attention for article published in BMC Cancer, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 197 Dimensions

Readers on

mendeley: 133 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Cholinergic agonism for the treatment of pancreatic cancer

Grant US-11344534-B2

United States of America

METHODS FOR TREATING METASTATIC PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING…

Application EP-3791876-A1

European Patent Office

METHODS FOR TREATING METASTATIC PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING…

Application WO-2017034957-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.